Intensive Hemodialysis: Applied Clinical Practice

Slides:



Advertisements
Similar presentations
Risk Stratification in Renal Care Mary Jane McKendry Vice President, Operations Fresenius Disease Management Optimal Renal Care.
Advertisements

Cardiac Risk In ESRD Patient
What Do I want ??? Sudhakar Venturi ST4.
Intradialytic Hypotension Fadel A. AlRowaie, MD,FACP,FNKF Assistant Professor of Medicine (KSAU-HS) Consultant Nephrologist Head of Nephrology (KFMC)
The FREEDOM Study (Impact of Short Daily Hemodialysis on Restless Legs Symptoms and Sleep Disturbances) Source Jaber BL, Schiller B, Burkart JM, et al.
NxStage® HHD Therapy Overview
Nuevas Soluciones en DP, Sirven? Prueba en diabéticos con transporte peritoneal alto y promedio alto Dr. José Ramón Paniagua Sierra Unidad de Investigación.
How best to control salt overload in hypertension? - Dietetic? - Aligning dialysate sodium with patient's serum sodium -Prohibition of sodium profiling.
Uncontrolled secondary hyperparathyroidism in a haemodialysis patient Jordi Bover, MD, PhD Fundació Puigvert Barcelona, Spain © Springer Healthcare, a.
End Stage Renal Disease in Children. End stage kidney disease occurs when the kidneys are no longer able to function at a level that is necessary for.
Renal Replacement Therapy: What the PCP Needs to Know.
Measurement and preservation of residual renal function (RRF) in haemodialysis patients Elizabeth Lindley and David Keane Leeds Teaching Hospitals NHS.
Calcium & phosphor disturbance CKD- MBD Dr. Atapour.
Hyperparathyroidism in Chronic Kidney Disease 醫五 李政霆.
 Heart failure is a complex clinical syndrome Can result from:  structural or functional cardiac disorder  impairs the ability of the ventricle to.
A E UROPEAN R ENAL B EST P RACTICE (ERBP) POSITION STATEMENT ON THE K IDNEY D ISEASE I MPROVING G LOBAL O UTCOMES (KDIGO) C LINICAL P RACTICE G UIDELINES.
Epoetin Alfa & Increased Mortality Maria Shin, Pharm.D. Pharmacy Resident (PGY-1) Kingsbrook Jewish Medical Center Clinical Instructor of Pharmacy Practice.
This lecture was conducted during the Nephrology Unit Grand Ground by Medical Student rotated under Nephrology Division under the supervision and administration.
Treatment of Hypertension in Patients on Hemodialysis
Hemoglobin A 1c in Hemodialysis Patients Source: Ix JH. Hemoglobin A1c in hemodialysis patients: Should one size fit all? Clin J Am Soc Nephrol. 2010;5:1539–1541.
Concept of dry weight in haemodialysis. Introduction   Achieving and maintaining dry-weight appears to be An effective but forgotten strategy in Controlling.
RENAL DISEASE IN DIABETES
CHRONIC RENAL FAILURE JAKUB ZÁVADA KLINIKA NEFROLOGIE 1.LF UK.
Heart Failure Ben Starnes MD FACC Interventional Cardiology
Systemic Hypertension. Systemic blood pressure measures 140/90 mm Hg or higher on at least two occasions a minimum of 1 to 2 weeks apart.
Hemodialysis. Hemodialysis (also haemodialysis) is a method for removing waste products such as potassium and urea, as well as free water from the blood.
VA/DoD 2006 Clinical Practice Guideline For Screening and Management of Overweight and Obesity Guideline Summary: Key Elements.
10/5/2015. Hypertension GuidelinesDate JNC JNC JNC NICE Guidelines 2011 ESC / ESH Hypertension Guidelines ESC Guideline2007.
Blood pressure control in primary health care WORKSHOP
Dialysis: outcome and complications. Introduction Outcomes – 20%+ of dialysis patients die each year, 3YS diabetics ~50% Technical complications –PD –Haemo.
Dietary Issues in Renal Complications Ulrich Wahl, Tamworth, 2010.
Exercise Management Chronic Heart Failure Chapter 12.
Stella Lawal NUR 532 Molloy College Response to the following questions  How many pair of kidney does a person has?  Where are they located?  What.
Nutritional management paediatric CKD Dr. CKD – Chronic kidney disease.
Long Term Peritoneal Dialysis In Children – Frequent Complications Conclusions: Peritoneal Dialysis is the method of choice for pediatric patients, with.
Dr.M.shafiee Department of internal medicine Shiraz university of medical sciences.
신장내과 R4 강혜란 Cardiorenal syndrome (CRS).  Patients with heart failure (HF) who have a reduced GFR -> Mortality ↑  Patients with chronic kidney disease.
Depression in chronic kidney disease 신장내과 R4 정우진 Mini topic.
Oral Phosphate Binders in Patients with Kidney Failure
A.M. Thompson, T.G. Pickering  Kidney International 
Optimization of pre-ESRD care: The key to improved dialysis outcomes
The HEMO Study Hemodialysis (HEMO) Study Reference
The EuLITE (Ongoing) Source
The EuLITE (Ongoing).
P689 THE ROLE OF NUTRITIONAL ASSESSMENT FOR SIMULTANEOUS
The ECHO Observational Study
CARDIOVASCULAR CORELATIONS IN CHILDREN WITH END STAGE RENAL DISEASE
Diseases of the Renal System
Current and future management of diabetic renal failure
Chronic kidney disease and pre-dialysis
Figure 5 A layered approach to the follow-up of patients with acute kidney disease (AKD) Figure 5 | A layered approach to the follow-up of patients with.
Hypertension in Dialysis Patients
Dialysis Options: What is the Best Choice for You. Ana C
Bakris GL, Burkhart JM, Weinhandl ED, McCullough PA, Kraus MA
Nat. Rev. Nephrol. doi: /nrneph
Figure 7 The efficacy of phosphate-binder therapy
Hypertension in Dialysis Patients
Figure 3 Societal costs for the care of patients with chronic kidney disease in the UK Figure 3 | Societal costs for the care of patients with chronic.
A Six-hour Hemodialysis Without a Significant Increase in Dialysis Dose, as Judged by Kt/V, Can Reduce the Dosage of Erythropoietin Department of Kidney.
Figure 1 Changes in relative plasma volume (RPV)
Both cardiovascular and non-cardiovascular diseases are important causes of death in dialysis patients: A comparison with the general population Minako.
Meeting the challenges of the new K/DOQI guidelines
Homocysteine and risk in end-stage renal disease: a matter of context
Dialysate Sodium: Choosing the Optimal Hemodialysis Bath
Diseases of the Renal System
David A. Goodkin, MD, Eric W
Hemodialysis patients represent a tiny subset of all patients with heart disease. Hemodialysis patients represent a tiny subset of all patients with heart.
Diseases of the Renal System
Optimization of pre-ESRD care: The key to improved dialysis outcomes
Álvares et al. Am J Nephrol 2017;45: (DOI: / )
Presentation transcript:

Intensive Hemodialysis: Applied Clinical Practice Increased Time and Frequency GUIDELINES FROM 5 MEDICAL SOCIETIES IN NORTH AMERICA, EUROPE AND ASIA

Proliferation of research about intensive hemodialysis has led to better understanding of when to increase hemodialysis time and frequency Since 2006, at least 5 medical societies from around the world have released clinical practice guidelines that are largely in agreement about appropriate indications OVERVIEW

NKF-KDOQI National Kidney Foundation Kidney Disease Outcomes Quality Initiative 2015 Consider additional hemodialysis sessions or longer hemodialysis treatment times for patients with:  large weight gains high ultrafiltration rates poorly controlled blood pressure difficulty achieving dry weight poor metabolic control (such as hyperphosphatemia, metabolic acidosis, and/or hyperkalemia) (Not Graded) National Kidney Foundation. KDOQI Clinical Practice Guideline for Hemodialysis Adequacy: 2015 Update. Am J Kidney Dis. 2015;66(5):884-930.

JSDT Japanese Society for Dialysis Therapy 2015 The dialysis time or frequency should be increased in the following patient situations: Patients with symptoms that cannot be controlled by conventional HD: cardiac failure or hemodynamic instability during dialysis hypertension despite fluid removal, the administration of antihypertensive agents, and the restriction of salt intakes hyperphosphatemia despite dietary controls and phosphate control Patients who are stable under conventional HD and are expected to benefit more from dialysis with increased dialysis times and/or frequencies. Watanabe Y, et al. Japanese Society for Dialysis Therapy Clinical Guideline for "Maintenance Hemodialysis: Hemodialysis Prescriptions". Ther Apher Dial. 2015;19(Suppl 1):67-92.

UK RA United Kingdom Renal Association 2011 We suggest that an increase in treatment and/or frequency of HD should be considered in patients with:  refractory fluid overload uncontrolled hypertension hyperphosphataemia malnutrition cardiovascular disease (2C) Mactier R, et al. Renal Association Clinical Practice Guideline on Haemodialysis. Nephron Clin Pract. 2011;118(Suppl 1):c241-286.

EBPG European Best Practice Guidelines 2007 An increase in treatment time and/or frequency should be considered in: patients with haemodynamic or cardiovascular instability (evidence level II) patients who remain hypertensive despite maximum possible fluid removal (evidence level III) patients with impaired phosphate control (evidence level III) malnourished patients (opinion) Tattersall J, et al. EBPG Guideline on Dialysis Strategies. Nephrol Dial Transplant. 2007;22(Suppl 2):ii5-21.

CSN Canadian Society of Nephrology 2006 Patients with poorly controlled BP: consider frequent hemodialysis (Grade D) or sustained hemodialysis (Grade C) Patients with significant left ventricular hypertrophy or impaired left ventricular systolic function: consider frequent hemodialysis as adjunctive therapy (Grade D) Patients who exhibit hemodynamic instability with conventional hemodialysis: consider frequent hemodialysis (Grade D, opinion) Patients with refractory hyperphosphatemia and/or secondary hyperparathyroidism: consider NHD as adjunctive therapy (Grade D, opinion) Patients with refractory peripheral vascular disease and ectopic calcification: consider NHD as salvage therapy (Grade D, opinion) Patients who exhibit chronic malnutrition: consider frequent hemodialysis as salvage therapy (Grade D, opinion) Jindal K, et al. Hemodialysis Clinical Practice Guidelines for the Canadian Society of Nephrology. J Am Soc Nephrol. 2006;17(3 Suppl 1):S1-27.

Physician judgment, coupled with guidelines, is key to identifying patients who, from a clinical perspective, would be good candidates for intensive hemodialysis. CONCLUSION

www.AdvancingDialysis.org